Aventura Private Wealth’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.3K Buy
359
+35
+11% +$5.25K 0.02% 325
2026
Q1
$49.5K Hold
324
– – 0.02% 325
2025
Q4
$44.7K Hold
324
– – 0.02% 310
2025
Q3
$41.5K Hold
324
– – 0.02% 317
2025
Q2
$39.2K Hold
324
– – 0.02% 306
2025
Q1
$36.1K Hold
324
– – 0.02% 295
2024
Q4
$31.5K Buy
+324
New +$34.6K 0.02% 296

Other funds holding NVS

Aventura Private Wealth's NVS Position: Q2 2026 in Review

Aventura Private Wealth increased its Novartis (NVS) stake by 11% in Q2 2026, buying an estimated $5.25K and bringing the position to 359 shares worth $56.3K. The position accounts for 0.02% of the portfolio, ranked #325.

Aventura Private Wealth first reported a position in NVS in Q4 2024 and has held it in 7 quarters since. 1,625 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Aventura Private Wealth held 359 shares of Novartis worth $56.3K as of Q2 2026.
  • Aventura Private Wealth bought 35 Novartis shares in Q2 2026, an estimated $5.25K.
  • Novartis made up 0.02% of Aventura Private Wealth's portfolio in Q2 2026, its #325 holding.
  • Aventura Private Wealth first reported a position in Novartis in Q4 2024 and has held it in 7 quarters since.
  • 1,625 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Aventura Private Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.